Skip to main content
Home

Main navigation

  • About HIPRA

      About HIPRA

    • Discover HIPRA
    • History
    • Sustainability & CSR
    • HIPRA Around the World
  • Animal Health
  • Human Health

      Human Health

    • Products & Services
      • Covid-19 Vaccine
      • Analysis Covid-19
      • GoodGut: digestive health
    • R&D projects
    • News
    • Press
  • Careers
  • Contact us
Career
Search
Search
who we are

News

HIPRA creates a committee of experts for the Covid-19 vaccine project

13-07-2022
Human
Corporate
Explore
comité expertos

HIPRA distinguished with the Creu de Sant Jordi

01-07-2022
Corporate
Explore
Creu de Sant Jordi HIPRA

HIPRA starts a Phase III clinical trial of the Covid-19 vaccine with immunocompromised participants

13-06-2022
Human
Explore
Ensayo vacuna HIPRA

HIPRA joins the "Voluntary Agreements Program"

01-04-2022
Corporate
Explore
voluntary commitment

EMA starts rolling review of Covid-19 HIPRA’s vaccine

29-03-2022
Human
Explore
European Medicines Agency

GoodGut and Vall d'Hebron are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

27-03-2022
Human
Explore
goodgut news
  • Load More
Home

Footer second

  • About HIPRA
  • Animal Health
  • Human Health

Footer third

  • Careers
  • Contact us

Footer fourth

  • LinkedIn
  • YouTube

Footer

  • Terms of use
  • Privacy policy
  • Cookies policy